Łukasz Liszka

Łukasz Liszka

Auto-generated profile, based on publicly available information

Łukasz Liszka

Department of Histopathology, Medical University of Silesia, Katowice, Poland

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2007 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
ŁLŁukasz Liszka
Łukasz Liszka
EZEwa Zielińska-Pająk
Ewa Zielińska-Pająk
JPJacek Pająk
Jacek Pająk
DGDariusz Gołka
Dariusz Gołka
JHJoanna Huszno
Joanna Huszno

4 March 2010 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
ŁLŁukasz Liszka
Łukasz Liszka
JPJacek Pająk
Jacek Pająk
EZEwa Zielińska‐Pająk
Ewa Zielińska‐Pająk
Łukasz J. KrzychŁukasz J. Krzych
Łukasz J. Krzych
DGDariusz Gołka
Dariusz Gołka
PLPaweł Lampe
Paweł Lampe

11 May 2006 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
ŁLŁukasz Liszka
Łukasz Liszka
DWDariusz Woszczyk
Dariusz Woszczyk
JPJacek Pająk
Jacek Pająk

1 December 2008 in Pathology
Verified
Journal Article
Closed access
PDF file
ŁLŁukasz Liszka
Łukasz Liszka
EZEwa Zielińska-Pajak
Ewa Zielińska-Pajak
JPJacek Pajak
Jacek Pajak
DGDariusz Gołka
Dariusz Gołka
Colloid carcinoma (CC) of the pancreas is a histopathological variant of ductal adenocarcinoma, which is characterised by the presence of large pools of extracellular mucin, containing neoplastic cells. The mucin component comprises at least 50% of CC (according to the definition by the World Health Organization) or at least 80% of the tumour (according to the US Armed Forces Institute of Pathology). In the vast majority of cases, CC develop from pre-existing intraductal papillary mucinous neoplasms, especially those forming intestinal-type papillae and characterised by MUC2 expression. Data concerning the long-term prognosis in patients with CC are discrepant. In this review, the authors present contemporary definitions of CC, issues of its epidemiology, symptomatology, preoperative diagnostics, histopathology, treatment and prognosis. Special attention has been paid to pathogenesis of CC.


29 November 2011 in Hepatology International
Verified
Journal Article
Open access
PDF file
MCMonika Ciupińska-Kajor
Monika Ciupińska-Kajor
MHMarek Hartleb
Marek Hartleb
MKMaciej Kajor
Maciej Kajor
Michael KuklaMichael Kukla
Michael Kukla
MWMariusz Wyleżoł
Mariusz Wyleżoł
ŁLŁukasz Liszka
Łukasz Liszka
Background A mass of visceral adipose tissue is one of the most important determinants of progressive liver injury in nonalcoholic fatty liver disease (NAFLD). In accordance, nonalcoholic steatohepatitis (NASH) and fibrosis are believed to occur more commonly in morbidly obese patients compared with nonobese NAFLD patients. Aim of the study Comparative analysis of NAFLD histopathologic features and angiogenesis activity in morbidly obese and nonobese subjects. Materials and methods Biopsy samples from 40 severely obese (BMI ≥40 kg m−2) and 30 nonobese (BMI ≤30 kg m−2) NAFLD patients were examined. Kleiner’s classification was used to diagnose NASH by grading steatosis, cytoplasmatic ballooning of hepatocytes, and lobular inflammation. The severity of fibrosis was evaluated according to the liver fibrosis staging system. Qualitative and quantitative immunohistochemical analyses of VEGF A, Flk-1, and CD34 were performed to study angiogenesis and the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method was used to study hepatocyte apoptosis. Results Severely obese patients did not differ from nonobese patients with respect to age and sex distribution. NASH was diagnosed in nine (22.5%) severely obese patients and in seven (23.3%) nonobese patients. Fibrosis was more common in morbidly obese patients (82.5 vs. 43.5%, χ² = 11.71, p = 0.003) and was not associated with NASH. Moreover, the severity of fibrosis was greater in obese patients, as advanced fibrosis (bridging fibrosis and cirrhosis) occurred in six (15%) severely obese patients and in two (6.7%) nonobese patients. In morbidly obese individuals, angiogenesis was independent of NASH and was activated at the stage of simple steatosis. In severe obesity, there was a positive relationship between the stage of fibrosis and angiogenic activity. Conclusion In severely obese patients, fibrosis is probably promoted by mechanisms independent of NASH. In these patients, angiogenesis is activated early in the natural history of NAFLD and correlates with the severity of fibrosis.